EXTEDO, a leading provider of Regulatory Information Management solutions and Wrike, a leading provider of cloud-based enterprise collaborative project management software, today announced the release of a new planning and tracking solution to help facilitate a solution for the COVID-19 virus.

Wrike is an all-in-one collaborative work management solution that allows its users to manage workflows securely at scale, turn strategies into actionable plans and drive operational excellence.

Benefitting from the years of experience with hundreds of Wrike clients, EXTEDO adapted the proven collaborative project management solution to the requirements for pharmaceutical companies and  the life sciences industry, and integrated it with the EXTEDO RIM platform. This allows users to benefit from the project management solution experience of Wrike along with over 20 years of EXTEDO’s experience within the pharmaceutical industry.

“With the current global COVID-19 pandemic, it is more important than ever to provide life sciences organizations with a solution that allows them to bring their products to market faster and safer while being able to keep track on necessary changes globally” said Martin Schmid, CEO at EXTEDO. “We are glad that with Wrike, we were able to find the right partner to drive operational excellence and ensure effortless compliance in the life sciences industry.”

Wrike for life sciences is seamlessly integrated with EXTEDO’s regulatory information management solution and allows users to plan and track activities related to submissions, drug safety and product registration. Wrike is already used by the marketing departments of numerous pharmaceutical organizations for their promotional material, which is then later compiled within EXTEDO’s eCTDmanager.

“The COVID-19 pandemic is affecting and impacting every business across the globe,” said Aharon Weiner, VP of Business Development, Wrike. “Since the onset of COVID-19, we have seen an increasing demand for a regulatory solution based on our technology. With EXTEDO’s experts on hand, the joint solution combines the best of both worlds.”

About Wrike

Wrike is the most versatile work management platform for the enterprise. It can be easily configured for any team and any use case to transform how work gets done. Wrike’s feature-rich platform puts teams in control of their digital workflows, enabling them to focus on the most important work, maximize potential, and accelerate business growth. More than 20,000 customers, including Hootsuite, Tiffany & Co., and Ogilvy, and 2M+ users across 140 countries depend on Wrike to help teams plan, manage, and complete work at scale. Wrike is headquartered in San Jose, CA. For more information, visit: https://www.wrike.com/.

Über die EXTEDO GmbH

EXTEDO was founded in 1996 as a department of IABG with a simple vision: to help life sciences organizations ensure Effortless Compliance with industry standards and regulatory requirements. EXTEDO is the only vendor that provides solutions covering the entire regulatory landscape. EXTEDO product portfolio combines innovation with compliance, and quality with usability. From Product Registration Planning & Tracking, to Submission Publishing & Lifecycle Management, to Pharmacovigilance Management and Drug Safety, we are here to optimize your e-Regulatory business processes. For more information, visit www.extedo.com

Firmenkontakt und Herausgeber der Meldung:

EXTEDO GmbH
Einsteinstrasse 30
85521 Ottobrunn
Telefon: +49 (89) 189454-0
Telefax: +49 (89) 189454-999
http://www.extedo.com

Ansprechpartner:
Ina Scharfen
Senior Marketing Manager & Team Lead Sales Operations
Telefon: +49 (89) 189454-139
Fax: +49 (89) 189454-980
E-Mail: scharfen@extedo.com
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel